External Validation of the 2003 Leibovich Prognostic Score in Patients Randomly Assigned to SORCE, an International Phase III Trial of Adjuvant Sorafenib in Renal Cell Cancer. (2022)

First Author: Oza B
Attributed to:  Cambridge Mathematics of Information in Healthcare (CMIH) funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1200/jco.21.01090

PubMed Identifier: 35213214

Publication URI: http://europepmc.org/abstract/MED/35213214

Type: Journal Article/Review

Volume: 40

Parent Publication: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Issue: 16

ISSN: 0732-183X